Cognition Therapeutics
CGTX
69 hedge funds and large institutions have $28.7M invested in Cognition Therapeutics in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 4 reducing their positions, and 8 closing their positions.
721% more capital invested
Capital invested by funds: $3.5M → $28.7M (+$25.2M)
475% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 4
288% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 8
44% more funds holding
Funds holding: 48 → 69 (+21)
10.83% more ownership
Funds ownership: 18.1% → 28.93% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
+$3.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.88M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.64M |
| 4 |
Jane Street
New York
|
+$1.24M |
| 5 |
BlackRock
New York
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$216K |
| 2 |
VC
Voss Capital
Houston,
Texas
|
-$205K |
| 3 |
CM
CM Management
Gulf Breeze,
Florida
|
-$77.5K |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$48.3K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$28.5K |
CGTX Hedge Fund Activity: Q3 2025 in Review
69 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q3 2025, worth a combined $28.7M — up 721% from $3.5M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new CGTX positions and 8 closed out — a net gain of 23 holders — while 23 added to existing stakes and 4 trimmed.
The largest buyer was Davenport & Co, opening a new position worth an estimated $3.67M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $216K sold.
- 69 institutional investors held Cognition Therapeutics (CGTX) as of Q3 2025, up from 48 in Q2 2025.
- Funds reported $28.7M of Cognition Therapeutics stock for Q3 2025, up 721% quarter-over-quarter.
- 31 funds opened new Cognition Therapeutics positions in Q3 2025 and 8 closed out, a net change of +23 holders.
- The largest Cognition Therapeutics buyer in Q3 2025 was Davenport & Co, an estimated $3.67M added.
- The largest Cognition Therapeutics seller in Q3 2025 was Acadian Asset Management, an estimated $216K sold.
Based on aggregated 13F filings for Q3 2025.